Recently, ANVISA published Resolution No. 168/2017, which sets protocols for the analysis of pharmaceutical patent applications. This Resolution allows applicants that deal with those types of patent applications to have a better understanding of the procedure within the regulatory agency.

http://diblasi.com.br/newsletter/anvisa-regulates-procedures-to-analyze-pharmaceutical-patent-applications/